Our portfolio has expanded to include testing for folate receptor alpha expression – learn more below.
Fill out the form below to get in touch with your dedicated Myriad sales representative.
* Required field
Contact Information
Through one ordering process, Precise Oncology Solutions can uncover the answers you need to optimize your patients’ treatment plans.
Precise Oncology Solutions combines germline and somatic testing onto one platform to help you and your staff save time, and get faster answers for your patients.
Test results arrive quickly, with an easy-to-interpret summary sheet to help you clarify your treatment decisions.
Your Precise Oncology Solutions order can include genetic and genomic tests to help determine your patients’ treatment options.
GERMLINE
[FDA-Approved]
[Non-FDA-Approved]
HRD† STATUS
IHC STAINS
TUMOR PROFILING
† For patients with ovarian cancer.
* Precise Tumor, PD-L1, and FOLR1/FRα are powered by Intermountain Precision Genomics, a service of Intermountain Health. Precise Tumor and MyRisk are not approved by the FDA. FOLR1/FRα is an FDA-approved assay performed according to the intended use.
Precise Oncology Solutions provides genetic testing options to support your patients’ care, regardless of where they are in their treatment journeys. The accurate genetic insights from our tests can help you choose the appropriate surgical technique or type of chemotherapy, identify patients who may qualify for clinical trials, aid your network of colleagues as they assess patients for additional care, and more.
Each month, we convene with clinical experts to review patient cases and discuss leading edge treatment strategies.
Topics of discussion may include:
Visit Myriad Live to learn more
This is not a CME event.